APA (7th ed.) Citation

Blank, A., Eidam, A., Hohmann, N., Burhenne, J., Meyer, M. R., Meier, K., . . . Haefeli, W. E. (2018). The NTCP-inhibitor Myrcludex B: Effects on bile acid disposition and tenofovir pharmacokinetics. Clinical pharmacology & therapeutics, 103(2), . https://doi.org/10.1002/cpt.744

Chicago Style (17th ed.) Citation

Blank, Antje, et al. "The NTCP-inhibitor Myrcludex B: Effects on Bile Acid Disposition and Tenofovir Pharmacokinetics." Clinical Pharmacology & Therapeutics 103, no. 2 (2018). https://doi.org/10.1002/cpt.744.

MLA (9th ed.) Citation

Blank, Antje, et al. "The NTCP-inhibitor Myrcludex B: Effects on Bile Acid Disposition and Tenofovir Pharmacokinetics." Clinical Pharmacology & Therapeutics, vol. 103, no. 2, 2018, https://doi.org/10.1002/cpt.744.